TECHNOLOGY

More information about our technologies

  MIDGE

  MIDGE-Th1

  dSLIM

CONTACT

Investor & Public Relations

  Mr. Joerg Petrass

Research & Development

  Dr. Matthias Schroff

Business Development

  Ms. Arlett Killat

NEWS

June 22, 2010

MOLOGEN AG receives approval for clinical study with cell-based gene therapy against renal cancer

  press release

  ad-hoc announcement

June 22, 2010

MOLOGEN AG starts phase 2 clinical study with DNA-based cancer medicine MGN1703 against colorectal cancer

  more